drugset / Trial / NCT04520373

Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients

NCT04520373

Phase 2 Active not recruiting 40 enrolled Mayo Clinic
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this research study is to investigate the safety and potential therapeutic effects of autologous, culture-expanded, adipose derived mesenchymal stem cell intrathecal injections in the treatment of spinal cord injury.

Timeline

Start
2020-06-25
Primary completion
2026-07
Completion
2026-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous adipose-derived mesenchymal stem cells Cell therapy Intrathecal